[go: up one dir, main page]

UY27043A1 - DERIVATIVES OF INDIRUBINA ARIL-SUBSTITUTES, ITS PREPARATION AND USE - Google Patents

DERIVATIVES OF INDIRUBINA ARIL-SUBSTITUTES, ITS PREPARATION AND USE

Info

Publication number
UY27043A1
UY27043A1 UY27043A UY27043A UY27043A1 UY 27043 A1 UY27043 A1 UY 27043A1 UY 27043 A UY27043 A UY 27043A UY 27043 A UY27043 A UY 27043A UY 27043 A1 UY27043 A1 UY 27043A1
Authority
UY
Uruguay
Prior art keywords
diseases
preparation
disease
derivatives
indirubina
Prior art date
Application number
UY27043A
Other languages
Spanish (es)
Inventor
Rolf Jautelat
Gerhard Siemeister
Olaf Prien
Andreas Steinmeyer
Michael Grimm
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Priority to UY27043A priority Critical patent/UY27043A1/en
Publication of UY27043A1 publication Critical patent/UY27043A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen derivados de indirubina aril-sustituidos, su preparación y los productos intermedios para su preparación, así como su uso como medicamento para el tratamiento de cánceres tales como tumores sólidos y leucemia, enfermedades autoinmunes,enfermedades infecciosas, enfermedades nefrológicas como por ejemplo, glomerulonefritis, enfermedades neurodegenerativas crónicas como enfermedad de huntingon, esclerosis lateral amiotrofica, enfermedad de parkinson, demencia por sida, y enfermedad de alzheimer, enfermedades neurodegenerativas agudas como isquemias cerebrales y traumas neuronales, infecciones virales como por ejemplo infecciones de citomegalovirus, herpes, hepatitis B y C, y enfermedades provocadas por VIH.Aryl-substituted indirubin derivatives, their preparation and intermediates for their preparation are described, as well as their use as a medicine for the treatment of cancers such as solid tumors and leukemia, autoimmune diseases, infectious diseases, nephrological diseases such as glomerulonephritis , chronic neurodegenerative diseases such as huntingon disease, amyotrophic lateral sclerosis, parkinson's disease, AIDS dementia, and Alzheimer's disease, acute neurodegenerative diseases such as cerebral ischemia and neuronal traumas, viral infections such as cytomegalovirus infections, herpes, hepatitis B and C, and diseases caused by HIV.

UY27043A 2001-11-27 2001-11-27 DERIVATIVES OF INDIRUBINA ARIL-SUBSTITUTES, ITS PREPARATION AND USE UY27043A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27043A UY27043A1 (en) 2001-11-27 2001-11-27 DERIVATIVES OF INDIRUBINA ARIL-SUBSTITUTES, ITS PREPARATION AND USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27043A UY27043A1 (en) 2001-11-27 2001-11-27 DERIVATIVES OF INDIRUBINA ARIL-SUBSTITUTES, ITS PREPARATION AND USE

Publications (1)

Publication Number Publication Date
UY27043A1 true UY27043A1 (en) 2002-07-31

Family

ID=38812536

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27043A UY27043A1 (en) 2001-11-27 2001-11-27 DERIVATIVES OF INDIRUBINA ARIL-SUBSTITUTES, ITS PREPARATION AND USE

Country Status (1)

Country Link
UY (1) UY27043A1 (en)

Similar Documents

Publication Publication Date Title
UY26982A1 (en) INDIRUBINE DERIVATIVES CONTAINING SULFUR, ITS PREPARATION AND USE
USD922295S1 (en) Wheel
EA200200249A1 (en) DERIVATIVES 3 (5) -UREIDOPYRAZOL, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS ANTI-TUMOR AGENTS
BG106480A (en) 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
EA200200247A1 (en) DERIVATIVES OF ARYLMETHYL CARBONYLAMINOTHIAZOLE AND THEIR APPLICATION AS ANTI-TUMOR MEDICINE
WO2005021568A3 (en) Novel tricyclic nucleosides or nucleotides as therapeutic agents
USD913858S1 (en) Electric vehicle
BR0113234A (en) Polymorphs of an epothilone analog
ES2194468T3 (en) USE OF INDIGOID BISINDOL DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR INHIBITING CYCLINE DEPENDENT KINASES.
BR0307819A (en) Tricyclic pyrazole derivatives, process for preparing them as antitumor agents
GT200300150A (en) KINASE INHIBITORS
RS115904A (en) Azolidinone-vinyl fused benzene derivatives
UY24895A1 (en) ARYLSULPHONAMIDES AND ANALOGS USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
USD510896S1 (en) Frontal configuration of a steering wheel
HK1147490A1 (en) Condensed aminodihydrothiazine derivative
MXPA02010627A (en) 2-acyl indol derivatives and their use as anti-tumour agents.
WO2004058392A3 (en) Intramolecular triplet-sensitized o-nitrophenylethyl photoprotective groups
PA8527401A1 (en) 7-OXO-PYRIDOPIRIMIDINAS (II)
ES2176263T3 (en) 5,6-DIHYDROPIRONAS DERIVED AS PROTEASA INHIBITORS AND ANTIVIRUS AGENTS.
WO2002074742A3 (en) Cdk-inhibitory indirubin derivatives having an increased solubility
GB1192029A (en) (Bornanemethyl) Amines
UY27043A1 (en) DERIVATIVES OF INDIRUBINA ARIL-SUBSTITUTES, ITS PREPARATION AND USE
USD913857S1 (en) Electric vehicle
USD937432S1 (en) Saliva test device
WO2004043402A3 (en) Modified nucleosides as antiviral agents

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150126